<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04372758</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0245</org_study_id>
    <nct_id>NCT04372758</nct_id>
  </id_info>
  <brief_title>Descriptive Study of Acute Spontaneous Spinal Cord Infarction</brief_title>
  <acronym>EDMIAS</acronym>
  <official_title>Descriptive Study of Acute Spontaneous Spinal Cord Infarction : EDMIAS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute spontaneous Spinal Cord Infarctions (SCI) are an uncommon cause of myelopathy (5%), but&#xD;
      their prognostic is heterogeneous and frequently severe. Positive diagnosis is difficult, one&#xD;
      quarter of initial MRIs are normal. Differential diagnosis with other transverse myelopathy&#xD;
      causes is a common issue. As in cerebral stroke, there are multiple causes and mechanisms in&#xD;
      spontaneous SCI, often difficult to clearly establish. There are also clinical and&#xD;
      radiological patterns, sometimes misleading, according to vascular territory and its expanse.&#xD;
&#xD;
      Due to its scarcity and heterogeneity, improving knowledge and medical care remains&#xD;
      difficult. Medical care is still badly codified in medical literature. Recently, diagnostic&#xD;
      criteria have been proposed to better identify SCI, provide earlier care and homogenize&#xD;
      future research. External validity and reproduction of these new criteria among acute&#xD;
      myelopathies are still to be validated.&#xD;
&#xD;
      While there is no established medical treatment in the initial care of spontaneous SCI, some&#xD;
      case reports show successful treatment with IV thrombolysis. Given the severe prognosis,&#xD;
      conventional treatment of strokes (thrombolysis, anticoagulant and antiplatelet), could be&#xD;
      considered on an individual scale, in a specific protocol. A better knowledge of&#xD;
      radio-clinical and security factors are necessary to support this approach.&#xD;
&#xD;
      In order to respond to these difficulties, a retrospective cohort will allow us to better&#xD;
      define epidemiological, clinico-radiological and prognostic features of spontaneous SCI. It&#xD;
      lays the foundation of a possible prospective multicentric cohort, necessary for specific&#xD;
      therapeutic studies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 30, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>description of a recent spontaneous SCI cohort</measure>
    <time_frame>10 years</time_frame>
    <description>Number of patients hospitalized for spontaneous SCI in the last 10 years in Montpellier and Nîmes University Hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>description of a recent spontaneous SCI cohort</measure>
    <time_frame>1 day</time_frame>
    <description>description of patients diagnosed with spontaneous SCI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies</measure>
    <time_frame>1 day</time_frame>
    <description>evaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analysis of relevant clinical and radiological criteria for positive diagnosis and prognosis</measure>
    <time_frame>1 day</time_frame>
    <description>analysis of relevant clinical and radiological criteria for positive diagnosis and prognosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 2015</measure>
    <time_frame>1 day</time_frame>
    <description>Description of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 2015</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retrospective evaluation of the potential candidates for IV thrombolysis</measure>
    <time_frame>1 day</time_frame>
    <description>Retrospective evaluation of the potential candidates for IV thrombolysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.</description>
  </secondary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Spinal Cord Infarction</condition>
  <condition>Spinal Cord Stroke</condition>
  <condition>Vascular Myelopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All spontaneous SCI registered in medicine services from june 2010 to june 2020 in&#xD;
        Montpellier University Hospital and Nîmes University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Hospitalized patients in a medical ward in Montpellier and Nîmes University Hospitals&#xD;
             with registered diagnosis of vascular myelopathy&#xD;
&#xD;
          -  And final diagnosis of spontaneous SCI after reviewing medical datas&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  non ischemic myelopathies : compression, hematomyelia, spinal DAVF, intramedullary&#xD;
             tumor, inflammatory, infectious or post-infectious myelitis, post-radiation&#xD;
             myelopathy,…)&#xD;
&#xD;
          -  secondary SCI : SCI following an aortic, cardiac or rachidian surgery, extracorporeal&#xD;
             circulation, post-hemodynamic shock&#xD;
&#xD;
          -  SCI without a cause&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Gaillard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurology</keyword>
  <keyword>Vascular disease</keyword>
  <keyword>Paraplegia</keyword>
  <keyword>Quadriplegia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

